HIGHLIGHTS
- who: Maria Chiara Buscarinu and collaborators from the Department of Neurosciences, Mental Health and Sensory Organs, Centre for Experimental Neurological Therapies (CENTERS), Faculty of Medicine and Psychology, Sapienza University, Rome, Italy have published the research work: Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment, in the Journal: (JOURNAL)
- what: The authors report the case of a 45-year-old Italian woman affected by RR-MS from 2011, when she had a diplopia and underwent a magnetic_resonance imaging (MRI) showing multiple contrast-enhancing lesions in her brain and spinal cord . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.